REFERENCE: Abstract: Late Breaking Clinical Trials, Session 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
LESLEE SHAW, Emory University, Atlanta
COMMENT: DANIEL JONES, AHA President, University of Mississippi, Jackson
Some patients with stable angina may be best treated by adding percutaneous intervention to optimal medical therapy. This is the finding of a “nuclear sub-study” of the COURAGE (Clinical Outcomes Using Revascularization and Aggressive Drug Evaluation) trial. Although the study found no benefit of adding angioplasty in most patients, the AHA conference heard from Leslee Shaw that if myocardial ischemia is monitored using Single Photon Emission Computed Tomography (SPECT), there could be a role for angioplasty in a subgroup of patients. Peter Goodwin talked with Dr Shaw after her presentation and then asked the American Heart Association President, Daniel Jones, for his assessment.
Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results
Further reading
Mandeep Mehra talks about his report in the New England Journal of Medicine on the inflammatory effects of COVID-19 infection and the implications...
Atrial fibrillation is prevented by exercise and life-long endurance athletes do not face the same elevated risks of stroke and heart disease from...
AMSTERDAM—Whether triple anti-thrombotic therapy should be accepted as generally the optimal approach for treating patients at high risk of...
AMSTERDAM — The SAVOR-TIMI 53 study in 16 000 patients has confirmed the efficacy of the DPP-4 inhibitor, saxagliptin, for controlling...
AMSTERDAM—Whether triple anti-thrombotic therapy should be accepted as generally the optimal approach for treating patients at high risk of...
AudioMedica News Young adults less likely to be diagnosed with hypertension than over 60s Play Episode Pause Episode Mute/Unmute Episode Rewind 10...